Developing Asian countries such as the China and India are lucrative markets for protein engineering, owing to increase in R&D investment by the biologics companies in these regions.
The report segments the global protein engineering market product, technology, protein type, end user, and region. Instruments accounted for the largest share of the global Protein engineering market, by product in 2014. However, services and software is expected to grow at the highest CAGR during the forecast period, owing to ongoing technological advancements in this segment.
Rational protein design accounted the largest share of protein engineering market, by technology in 2014. This large share is attributed to increase in adoption of this technique over irrational protein design.
Based on protein type, the market is categorized into monoclonal antibodies, insulin, erythropoietin, interferon, colony stimulating factor, growth hormones, coagulation factor, vaccines and others (interleukins, follicle stimulating hormones, enzyme replacement). Monoclonal antibodies is the largest as well as fastest growing segment of the protein engineering protein type market. This growth is attributed to the increase in adoption of them for various therapies such as cancer and autoimmune diseases.
On the basis of end user, the protein engineering market is categorized academic research institutes, pharmaceutical and biotechnology companies, and contract research organizations. Pharmaceutical and biotechnology companies is the largest and fastest-growing end user segment. The high growth rate of this segment can be attributed to technological advancements in protein engineering and the increase in R&D budgets in the pharmaceutical sector.
New and innovative product launches was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.
From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the protein engineering market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.